Patents by Inventor Justin Hughey

Justin Hughey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080075770
    Abstract: Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.
    Type: Application
    Filed: July 20, 2007
    Publication date: March 27, 2008
    Inventors: Jason Vaughn, Michael Crowley, Feng Zhang, John Koleng, Justin Keen, Justin Hughey
  • Publication number: 20080075771
    Abstract: Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid antagonists that are sequestered from the opioid therapeutic agent such that the opioid antagonist has no substantial effect on the activity of the opioid therapeutic agent when the dosage form is taken orally as prescribed, but the opioid antagonist is released in an amount that reduces the effectiveness of the opioid therapeutic agent contained in the dosage form when the dosage form is crushed.
    Type: Application
    Filed: July 20, 2007
    Publication date: March 27, 2008
    Inventors: Jason Vaughn, Michael Crowley, Feng Zhang, John Koleng, Justin Keen, Justin Hughey
  • Publication number: 20080075768
    Abstract: Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid antagonists that are sequestered from the opioid therapeutic agent such that the opioid antagonist has no substantial effect on the activity of the opioid therapeutic agent when the dosage form is taken orally as prescribed, but the opioid antagonist is released in an amount that reduces the effectiveness of the opioid therapeutic agent contained in the dosage form when the dosage form is crushed.
    Type: Application
    Filed: July 20, 2007
    Publication date: March 27, 2008
    Inventors: Jason Vaughn, Michael Crowley, Feng Zhang, John Koleng, Justin Keen, Justin Hughey
  • Publication number: 20080069871
    Abstract: Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.
    Type: Application
    Filed: July 20, 2007
    Publication date: March 20, 2008
    Inventors: Jason Vaughn, Michael Crowley, Feng Zhang, John Koleng, Justin Keen, Justin Hughey
  • Publication number: 20080020032
    Abstract: Disclosed herein are oral dosage forms of hydromorphone that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.
    Type: Application
    Filed: July 20, 2007
    Publication date: January 24, 2008
    Inventors: Michael Crowley, Feng Zhang, John Koleng, Justin Keen, Jason Vaughn, Justin Hughey